Show simple item record

dc.contributor.author Reis, H
dc.contributor.author Szarvas, Tibor
dc.date.accessioned 2019-10-03T08:20:31Z
dc.date.available 2019-10-03T08:20:31Z
dc.date.issued 2018
dc.identifier.citation journalVolume=39;journalTitle=PATHOLOGE;pagerange=291-300;journalAbbreviatedTitle=PATHOLOGE;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/7731
dc.identifier.uri doi:10.1007/s00292-018-0498-7
dc.description.abstract Urachal cancer is arare but aggressive disease. In addition to the non-glandular tumors, non-cystic urachal adenocarcinomas are nowadays distinguished from the primary cystic variant. (Immunohistochemical) markers are only of minor differential diagnostic value and, therefore, the diagnosis is primarily established in amultidisciplinary approach. The non-cystic variant accounts for the majority of cases (83%), is more common in men (63%), shows amedian age at diagnosis of 51years and has a5-year survival rate of about 50%. In organ-confined disease, usually apartial cystectomy of the tumor in the bladder dome, including the median umbilical ligament and umbilicus, is performed. In advanced stages, systemic therapy is needed while 5-fuorouracil (5-FU) containing regimes have been shown to be more effective. Due to the rarity of the tumor, targeted therapy approaches based on abiological rationale are becoming increasingly relevant. As molecular data are still sparse, we compiled and analyzed the largest urachal cancer cohort to date. In 31% of the cases, MAPK-/PI3K signaling pathway alterations were detected (especially in K-/NRAS) with implications for anti-EGFR therapy approaches. Further potentially therapeutic alterations were detected in FGFR1, MET, PDGFRA, and erbB2/HER2. Additionally, PD-L1 tumor cell expression (clone: 22C3) was demonstrated in 16% of cases, therefore making anti-PD-1/PD-L1 immuno-oncological approaches worth considering despite the absence of mismatch repair deficiency (MMR-d) and/or high microsatellite instability (MSI-h). Finally, urachal adenocarcinomas seem to be adistinct entity on the molecular level with closer resemblance to colorectal adenocarcinomas than to urothelial carcinomas.
dc.format.extent 291-300
dc.relation.ispartof urn:issn:0172-8113
dc.title Urachal cancer - current concepts of a rare cancer
dc.type Journal Article
dc.date.updated 2019-09-12T18:51:44Z
dc.language.rfc3066 de
dc.rights.holder NULL
dc.identifier.mtmt 30558996
dc.identifier.wos 000453565100021
dc.contributor.department SE/AOK/K/Urológiai Klinika
dc.contributor.institution Semmelweis Egyetem


Files in this item

xmlui.dri2xhtml.METS-1.0.onlyFromAllowedIP

View/Open

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account